Offer - Urjas Oil for just ₹ 1
Symbiva 100 Rheocap, a prescription drug, is manufactured in various forms such as Capsule. It is primarily used for the treatment of Asthma. Other than this, Symbiva 100 Rheocap has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Symbiva 100 Rheocap depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Symbiva 100 Rheocap include Nasopharyngitis, Headache, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Symbiva 100 Rheocap as well, which are listed below. Such side effects of Symbiva 100 Rheocap normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Symbiva 100 Rheocap is Moderate for pregnant women and Moderate for women who are breastfeeding. It is important to know if Symbiva 100 Rheocap has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Symbiva 100 Rheocap related warnings section.
Other contraindications of Symbiva 100 Rheocap have been discussed in the sections ahead.
Drug reaction of Symbiva 100 Rheocap with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Symbiva 100 Rheocap is safe while driving, and is is addictive in nature.
Symbiva 100 Rheocap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Symbiva 100 Rheocap safe for pregnant women?
Pregnant women may experience moderate side effects from Symbiva. It is best to stop taking Symbiva immediately and inform your doctor if you notice any discomfort.
Is the use of Symbiva 100 Rheocap safe during breastfeeding?
Symbiva can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Symbiva 100 Rheocap on the Kidneys?
There are no side effects of Symbiva on the kidneys.
What is the effect of Symbiva 100 Rheocap on the Liver?
Symbiva does not damage the liver.
What is the effect of Symbiva 100 Rheocap on the Heart?
Symbiva is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 100 Rheocap unless your doctor advises you to do so -
Is this Symbiva 100 Rheocap habit forming or addictive?
No, you will not get addicted to Symbiva 100 Rheocap.
Is it safe to drive or operate heavy machinery when consuming?
Symbiva 100 Rheocap will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Symbiva 100 Rheocap should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Symbiva 100 Rheocap in mental disorders is not effective.
Interaction between Food and Symbiva 100 Rheocap
Taking Symbiva 100 Rheocap with food is safe.
Interaction between Alcohol and Symbiva 100 Rheocap
Taking Symbiva 100 Rheocap with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca
